Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HepaStem in Pediatric Urea Cycle Disorders
NCT02489292Phase 2Completed
- Sponsor
- Cellaïon
- Start
- Oct 2014
- Primary completion
- Mar 2017
- Modality
- Mesenchymal Stem Cells
- Countries
- 4
01
Overview
A Phase 2 trial of hepastem in urea cycle disorders (UCD), sponsored by Cellaïon. Started Oct 2014; status: completed.
02
Drugs
hepastem
03
Conditions
urea cycle disorders (UCD)
Beyond the preview
Go deeper on NCT02489292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489292.